| Objective:To observe the clinical effect of the capsule of ShengXueKang in treating the chronic idiopathic thrombocytopenic purpura(CITP),explaining the acting role and the immune function mechanism of this medicineT.To explore the possible relationships between the differentiating syndrome typing and differentiating disease effect. Methods:The Mongolian medicine of the capsule of ShengXueKang treats to CITP.To set off 60 patients ,30 patients was the treatment group and 30 patients was the control group.We treated CITP patients with QiangDiSong of 1-2mg/kg/day and the capsule of ShengXueKang that daily dosage 3g ,the control group use for QiangDiSong of 1-2mg/kg/day .The treatment course of both groups was one month,After a month we observed the these items'changes such as the clinical effect ,blood routine ,bone marrow megakaryocyte,immune index between the treatment group and the... |
PDF Full Text Request